JB Chemicals & Pharmaceuticals has informed that a meeting of the Board of Directors of the Company will be held on May 20, 2016, to consider and approve audited financial statements for the year ended on March 31, 2016, and to consider recommendation of final dividend for the F.Y. 2015-16.
The above information is a part of company’s filings submitted to BSE.